Patients with ER - negative, but not ER - positive, isolated
locoregional recurrence after unilateral breast cancer derive significant benefit from chemotherapy.
The rate of
locoregional recurrence (in the breast and surrounding area) was not significantly different between groups: 1.3 percent for women who had lipofilling versus 2.4 percent in those who did not.
Not exact matches
The results show no increase in the risk of
locoregional or systemic
recurrence in women with breast cancer who undergo breast reconstruction with lipofilling.